FIELD: medicine, peptides, biochemistry. SUBSTANCE: invention relates to novel biologically active substances. Peptide of the formula: H-Tyr-X-Y-Glu-OH where X means Gln and/or Gly; Y means Cys (acm) and/or Cys and its composition show both immunosuppressive property and ability to induce suppressive activity of mononuclear cells in human peripheral blood. Invention provides preparing the novel synthetic peptide and composition exhibiting the expanded functional capacities and simple method for preparing. EFFECT: simplified preparing, valuable medicinal properties. 3 cl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE COMPOSITION ELICITING IMMUNITY REGULATING PROPERTY | 2003 |
|
RU2244719C1 |
| PEPTIDE COMPOSITION POSSESSING IMMUNOREGULATORY PROPERTY | 2004 |
|
RU2266297C1 |
| AGENT FOR TREATING AUTOIMMUNE DISEASES | 2013 |
|
RU2528337C1 |
| AGENT POSSESSING IMMUNOREGULATORY PROPERTY AND ITS USING IN TREATMENT OF AUTOIMMUNE DISEASES | 2006 |
|
RU2303995C1 |
| AGENT FOR TREATMENT OF AUTOIMMUNE DISEASES WITH SUPPRESSOR IMMUNODEFICIENCY AND A METHOD OF AUTOIMMUNE DISEASES TREATMENT | 1994 |
|
RU2056852C1 |
| METHOD FOR INCREASING PROLIFERATIVE ACTIVITY OF PERIPHERAL BLOOD LYMPHOCYTES | 2010 |
|
RU2465001C2 |
| HLA-A*1101-LIMITED PEPTIDE WT1 AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT | 2007 |
|
RU2481398C2 |
| CYTOTOXIC T-CELL (CTC) INDUCING PEPTIDE, METHOD OF INDUCING CTC, ANTIBODY BOUND TO SAID PEPTIDE, USE OF SAID PEPTIDE IN PHARMACEUTICAL COMPOSITION AND FOR TREATING OR PREVENTING CANCER, ANTIGEN-PRESENTING CELL | 2006 |
|
RU2424247C2 |
| VACCINE COMPOSITION FOR MALIGNANT TUMOR | 2013 |
|
RU2721574C2 |
| HLA A*3303-RESTRICTED PEPTIDE WT1 AND PHARMACEUTICAL COMPOSITION CONTAINING SAID PEPTIDE | 2007 |
|
RU2435782C2 |
